Sign Up to Receive Your Personalised Learning Resources
Start Learning
Advancing Rheumatology Through Innovation, Education and Patient-Centred Care: An Interview with Future Leader Dr Sham Santhanam
Clinical Phenotyping and Molecular Endotyping in Osteoarthritis – Personalised Approaches to Therapeutics: Ali Mobasheri, WCO-IOF-ESCEO 2025
RGB-19 Matches Tocilizumab in Efficacy and Safety: Promising Phase III Data from RA Biosimilar Trial
Bridging Bench and Bedside: Future Leader, Dr Sonali Bracken on Autoimmunity, B Cell Research, and the Future of Rheumatology
UCB, making a difference in immunology
Advancing Osteoarthritis Research Through Immunology and Clinical Insight: An Interview with Future Leader, Dr Tom Appleton
Breakfree-1: Next-Gen CD19 CAR T Shows Promising Immune Reset Potential in Refractory Systemic Sclerosis
Medics For Rare Disease – New Year, New Strategy
Novel anti-CD6 monoclonal antibody, itolizumab, showcases proof of concept in ulcerative colitis
Navigating the management of cholestatic pruritus in patients with PBC: Insights from the multidisciplinary team
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
RMDs: What to Expect in 2025
View
European Commission approval of upadacitinib 15 mg for the treatment of giant cell arteritis in adult patients
View
Advancing Vasculitis Care and Medical Education: An Interview with Future Leader, Dr Brian Jaros
View
Clinical Approach to the Care of Patients with Immune Checkpoint Inhibitor-associated Inflammatory Arthritis
View
FDA approves bimekizumab for psoriatic arthritis, ankylosing spondylitis and axSpA
View
Bridging Research and Clinical Practice in Hepatology: EASL’s Approach to Liver Disease in Europe
View
Epinephrine 1mg Nasal Spray Gains Approval for Type I Allergic Reactions in Children Over 4 Years, who Weigh 15 to <30 kg
View
Dr Vinod Ravindran joins touchREVIEWS in RMD Editorial Board – Bringing a Wealth of Knowledge in Clinical Rheumatology
View
What’s New in the 2025 ACG Crohn’s Disease Guidelines: Personalized Care and Advanced Therapies
View
Increased infliximab clearance in patients hospitalized with severe ulcerative colitis may lead to underexposure
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
